GILD
Gilead Sciences Inc.
NasdaqGS
People also watch:CELGBIIBAMGNREGNFB
81.400.35 (0.44%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close81.05
Open81.30
Bid81.51 x 300
Ask81.53 x 900
52wk Range77.92 - 120.37
Day's Range81.06 - 81.85
Volume5,245,715
Avg Vol (3m)10,165,517
As of 11:04 AM EDT. NasdaqGS Real Time Price. Market open.
  • The Drug-Price War Just Took a Big New Twist
    Motley Fool43 minutes ago

    The Drug-Price War Just Took a Big New Twist

    As states and insurers are forced to unlock access to pricey hep-C wonder drugs, the wind may be shifting in favor of biotech and pharma investors.

  • Barrons.com46 minutes ago

    Yes, Biotech Stocks are Still Ridiculously Cheap (But Only if You Exclude Gilead)

    Leerink's Geoffrey Porges and Bradley Canino compare the valuation of biotech stocks (not including Gilead Sciences (GILD)) to other sectors of the market and find that--surprise, surprise--they look cheap: We find that large cap biotech’s growth outlook (Ex-Gilead) is still above the growth outlook for the overall market, and for medtech and pharma stocks as well. Due to the shorter history of these businesses, the analysis was conducted only for the post-2005 period.